PADAGIS ANNOUNCES FDA APPROVAL AND LAUNCH OF A-RATED GENERIC VERSION OF UCERIS® (BUDESONIDE 2MG RECTAL FOAM) ...Middle East

ALLEGAN, Mich., April 28, 2023 /PRNewswire/ -- Padagis today announced the launch of Budesonide 2mg Rectal Foam (generic to Uceris®) with 180-days of Competitive Generic Therapy exclusivity. Uceris® is a prescription corticosteroid medicine used to help get active, mild to moderate...

Read More Details
Finally We wish PressBee provided you with enough information of ( PADAGIS ANNOUNCES FDA APPROVAL AND LAUNCH OF A-RATED GENERIC VERSION OF UCERIS® (BUDESONIDE 2MG RECTAL FOAM) )

Also on site :

• Ukraine-Russia war latest: Putin will take revenge for Kyiv’s drone attack, warns Trump after phone call
• US-backed GHF group extends closure of Gaza aid sites for second day
• Becoming WPP’s CEO wasn’t on Mark Read’s ‘roadmap’—today he’s transforming the advertising giant with AI